Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 4,067	$ 2,983
General and administrative	15,130	1,456
Total operating expenses	19,197	4,439
Loss from operations	(19,197)	(4,439)
Other (expense) income:
Interest income	23	2
Loss on change of fair value of Sponsor Earn-Out liability	(7,688)
Other (expense) income, net	(160)	842
Total other (expense) income, net	(7,825)	844
Loss before income taxes	(27,022)	(3,595)
Provision for income taxes	(11)
Net loss	(27,033)	(3,595)
Other comprehensive income (loss):
Foreign currency translation adjustment	109	(14)
Total comprehensive loss	$ (26,924)	$ (3,609)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.12)	$ (0.06)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.12)	$ (0.06)
Weighted-average shares outstanding, basic (in shares)	219,180,317	60,781,975
Weighted-average shares outstanding, diluted (in shares)	219,180,317	60,781,975